InvestorsHub Logo
Followers 2
Posts 127
Boards Moderated 0
Alias Born 07/25/2022

Re: Doc logic post# 715380

Saturday, 08/24/2024 11:41:15 AM

Saturday, August 24, 2024 11:41:15 AM

Post# of 776379
I think a better idea for an upfront cash infusion(s) would be for a, or a few, BP(s) to buy 10% of NWBO for $10B in cash each. Plus, the BP(s) could get preferred terms in the licensing program, a BOD seat and maybe a 1 year right of refusal to match any bid to buy NWBO. Bp(s) would then own a small but important part of the future of curing all cancers, plus multiple other diseases. There would be a limit to only 3 such deals. The BOD would be increased to 8 seats, with current NWBO seats being 5, plus the 3 BP's each having 1 seat. If these potential buyers were to increase beyond just BP's, say to Berkshire Hathaway type companies, plus big hedge funds, etc, there are hundreds of entities worldwide to which a $10B investment is easily affordable.
Bp's/investors would be privileged to have insider knowledge and influence, but not control, over future development programs. BP's/investors could also be allowed to create manufacturing hubs in a hundred large cities and small countries for extra revenue/profit possibilities.
This would be a win for current NWBO shareholders and a win for the 3 BP's/investors shareholders, and a win for cancer victims wordwide, and get all DCVax products to market much, much faster.
With $30B in cash, I would expect NWBO to declare a one time dividend in the area of $15B.
Of course the $10B price for the 3 investors could be, say, half cash and half stock to NWBO's current shareholders to minimize capital gains tax consequences.
If anything like this scenario were to occur, NWBO's sp would skyrocket to about $70/share.
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News